Perceptive Advisors’s Acadia Healthcare ACHC Stock Holding History

Perceptive Advisors’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	–	–	129
2017 Q1	$0	Buy	+1	New	+$41	﹤0.01%	164

Other funds holding ACHC

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors's ACHC Position: Q2 2017 in Review

Perceptive Advisors sold out of Acadia Healthcare (ACHC) in Q2 2017, closing a stake of 1 share.

Perceptive Advisors first reported a position in ACHC in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 249 funds tracked by Wall St. Rank hold ACHC as of Q2 2017.

Perceptive Advisors reported no remaining Acadia Healthcare position as of Q2 2017 after selling out during the quarter.
Perceptive Advisors sold 1 Acadia Healthcare share in Q2 2017.
Perceptive Advisors first reported a position in Acadia Healthcare in Q1 2017 and held it in 1 quarter.
Perceptive Advisors's Acadia Healthcare position peaked at $0 in Q1 2017.
249 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2017.

Based on Perceptive Advisors's 13F filing for Q2 2017, filed 14 Aug 2017.